Skip to main content
SpringerLink
Log in

REPLY to ASTRAL Letter

  • Letter to the Editor
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The ASTRAL Trial Investigators (2009) Revascularization versus best medical therapy for renal artery stenosis. N Engl J Med 361:1952–1962

    Google Scholar 

  2. Alfke H, Radermacher J (2010) Renal artery stenting is no longer indicated after ASTRAL: pros and cons. Cardiovasc Intervent Radiol 33:883–886

    Article  PubMed  Google Scholar 

  3. Controversies––the ASTRAL trial. (2002) J Renovasc Dis 1:19–23

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Diagnostic and Interventional Radiology, Paulmannshöher Str. 14, 58515, Luedenscheid, North Rhine–Westphalia Land, Germany

    Heiko Alfke & Klinikum Luedenscheid

Authors
  1. Heiko Alfke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klinikum Luedenscheid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heiko Alfke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alfke, H., Luedenscheid, K. REPLY to ASTRAL Letter. Cardiovasc Intervent Radiol 34, 255–256 (2011). https://doi.org/10.1007/s00270-011-0116-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0116-z

Keywords

Search

Navigation